Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 24Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 11Lung Neoplasms 8Neoplasms 7Prostatic Neoplasms 6Pancreatic Neoplasms 6Colorectal Neoplasms 6Melanoma 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Hematologic Neoplasms 4Esophageal Neoplasms 4Multiple Myeloma 3Carcinoma, Renal Cell 3COVID-19 3Barrett Esophagus 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Papillomavirus Infections 2Ovarian Neoplasms 2Leukemia, Myeloid, Acute 2Genetic Predisposition to Disease 2Endometrial Neoplasms 2Diabetes Mellitus 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Breast Adenocarcinoma 2Anatomic Stage I Breast Cancer AJCC v8 2Uveal Melanoma 1

Interventions

Surveys and Questionnaires 9Cystectomy 6Blood Specimen Collection 5Neoadjuvant Therapy 4Cystoscopy 4Drug Therapy 3avelumab 2Urination 2Urinary Diversion 2Surgical Procedures, Operative 2Radiotherapy 2Pioglitazone 2Microarray Analysis 2Methods 2Magnetic Resonance Spectroscopy 2Interviews as Topic 2Immunohistochemistry 2Defecation 2Biopsy 25-aminolevulinic acid hexyl ester 2trastuzumab deruxtecan 1sargramostim 1pembrolizumab 1erdafitinib 1enfortumab vedotin 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1Watchful Waiting 1Urinary Sediment Analysis 1Therapeutics 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Urinary Bladder Neoplasms × Specimen Handling × Clear all
NCT02053662 2025-03-21

Biomarker Identification for Bladder Cancer Patients

Ohio State University Comprehensive Cancer Center

Terminated
179 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡